UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

 

Dermira Inc.

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

24983L104

(CUSIP Number)

 

January 31, 2020

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

x Rule 13d-1(b)
o Rule 13d-1(c)
o Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

CUSIP No. 24983L104
 
  1. Names of Reporting Persons
Alger Associates, Inc. 13-3017981
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) o
    (b) o
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
New York

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
5. Sole Voting Power
51,760
 
6. Shared Voting Power
0
 
7. Sole Dispositive Power
51,760
 
8. Shared Dispositive Power
0

 

  9. Aggregate Amount Beneficially Owned by Each Reporting Person
51,760
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
 
  11. Percent of Class Represented by Amount in Row (9)
0.09%
 
  12. Type of Reporting Person (See Instructions)
HC

 

2

 

 

CUSIP No. 24983L104
 
  1. Names of Reporting Persons
Alger Group Holdings, LLC
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) o
    (b) o
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
Delaware

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
5. Sole Voting Power
51,760
 
6. Shared Voting Power
0
 
7. Sole Dispositive Power
51,760
 
8. Shared Dispositive Power
0

 

  9. Aggregate Amount Beneficially Owned by Each Reporting Person
51,760
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
 
  11. Percent of Class Represented by Amount in Row (9)
0.09%
 
  12. Type of Reporting Person (See Instructions)
HC

 

3

 

 

Item 1.
  (a) Name of Issuer
Dermira Inc.
  (b) Address of Issuer’s Principal Executive Offices
275 Middlefield Rd, Suite 150,
Menlo Park, CA 94025
 
Item 2.
  (a)

Name of Person Filing
Alger Associates, Inc.

Alger Group Holdings, LLC

  (b) Address of Principal Business Office or, if none, Residence
360 Park Avenue South, New York, NY 10010
  (c)

Citizenship
Alger Associates, Inc. – New York

Alger Group Holdings, LLC – Delaware

  (d) Title of Class of Securities
Common Stock
  (e) CUSIP Number
24983L104
 
Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
  (a) o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
  (b) o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
  (c) o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
  (d) o Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
  (e) o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
  (f) o An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
  (g) x A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
  (h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
  (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
  (j) o A non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J);
  (k) o Group, in accordance with § 240.13d–1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J), please specify the type of institution:____________________________

 

4

 

 

Item 4. Ownership
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
  (a)

Amount beneficially owned:

51,760

  (b)

Percent of class:

0.09%

  (c)

Number of shares as to which the person has:

 

    (i)

Sole power to vote or to direct the vote

51,760

    (ii)

Shared power to vote or to direct the vote

0

    (iii)

Sole power to dispose or to direct the disposition of

51,760

    (iv)

Shared power to dispose or to direct the disposition of

0

 
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   x.
 
Item 6. Ownership of More than Five Percent on Behalf of Another Person

The securities reported herein are beneficially owned by one or more open-end investment companies or other managed accounts that are investment management clients of Fred Alger Management, LLC, (“FAM”) and Weatherbie Capital, LLC (“WC”), each a registered investment adviser. FAM and WC are 100% owned subsidiaries of Alger Group Holdings, LLC (“AGH”), a holding company. AGH is a 100% owned subsidiary of Alger Associates, Inc., a holding company.

 
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
See Exhibit A
 
Item 8. Identification and Classification of Members of the Group
 
Item 9. Notice of Dissolution of Group

 

5

 

 

Item 10. Certification

 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

By: Alger Associates, Inc.  
By: /s/ Hal Liebes  
Name: Hal Liebes  
Title: Secretary  
Date: February 10, 2020  
   
By: Alger Group Holdings, LLC  
By: /s/ Hal Liebes  
Name: Hal Liebes  
Title: Secretary  
Date: February 10, 2020  

  

6

 

 

Exhibit A

 

Pursuant to Item 7 of this schedule, the following lists the identity and item 3 classification of each entity that directly beneficially owns shares of the security class being reported.

 

Fred Alger Management, LLC — IA

Weatherbie Capital, LLC — IA

 

 

 

Joint Filing Agreement

 

The undersigned hereby agree that this Schedule 13G (the “Schedule 13G”) with respect to the common stock of Dermira Inc. is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate. It is understood and agreed that the joint filing of the Schedule 13G shall not be construed as an admission that the persons named herein constitute a group for purposes of Regulation 13D-G of the Securities Exchange Act of 1934, nor is a joint venture for purposes of the Investment Company Act of 1940.

 

 

By: Alger Associates, Inc.  
By: /s/ Hal Liebes  
Name: Hal Liebes  
Title: Secretary  
Date: February 10, 2020  
   
By: Alger Group Holdings, LLC  
By: /s/ Hal Liebes  
Name: Hal Liebes  
Title: Secretary  
Date: February 10, 2020  

  

Journey Medical (NASDAQ:DERM)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Journey Medical Charts.
Journey Medical (NASDAQ:DERM)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Journey Medical Charts.